>July 24, 2024 — Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
July 24, 2024
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...
July 24, 2024
July 23, 2024 — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award ...
July 23, 2024
July 23, 2024 — The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper ...
July 23, 2024
July 19, 2024 — The Society of Cardiovascular Computed Tomography (SCCT) received near-record breaking submissions of ...
July 19, 2024
July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...
July 18, 2024
July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...
July 18, 2024
On July 16, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows ...
July 16, 2024
July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...
July 15, 2024
July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...
July 15, 2024
July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...
July 11, 2024
July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...
July 11, 2024
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...
July 11, 2024
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
July 10, 2024
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 10, 2024